Literature DB >> 7586805

Detection of candidates for cancer cell motility inhibitory protein in the Dunning adenocarcinoma model.

J L Mohler1, W E Bakewell, Y Sharief, W B Coleman, C H Chay, S M Silvers, G J Smith.   

Abstract

The more differentiated components of a primary tumor may produce substances that reduce the growth rate and metastatic potential of more aggressive components. In the Dunning R-3327 prostatic adenocarcinoma model, cancer cell motility is required for metastatic potential. Medium conditioned by the non-motile, non-metastatic G subline contains proteins of molecular weight 50-100 kDa that inhibited the motility of the highly motile, highly metastatic MAT-LyLu subline. G subline-conditioned medium was separated by DEAE-cellulose chromatography using a linear gradient of 0-0.5 M NaCl in 100 mM Tris at pH 8.3. The motility inhibitory activity of G-conditioned medium was localized to column fractions 51-70 that contained 18% of the applied protein and only 6.5% of the proteins secreted by the G cells. Analysis of pooled fractions 51-60 and 61-70 by two-dimensional gel electrophoresis identified five protein families, with a total of 12 charged proteins of molecular weights approximating 66, 54, 50, 41 and 34 kDa, that were not present or present in reduced quantities in column fractions that did not inhibit motility. Isolation and identification of motility inhibitory protein may prove it the first substance discovered that is produced by a more differentiated component of a neoplasm that directly inhibits a metastasis-associated property.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7586805     DOI: 10.1007/BF00118186

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  31 in total

1.  Inhibition of growth factor effects in retinal pigment epithelial cells.

Authors:  K H Leschey; J Hines; J H Singer; S F Hackett; P A Campochiaro
Journal:  Invest Ophthalmol Vis Sci       Date:  1991-05       Impact factor: 4.799

2.  Cell biology. Motility factors on the march.

Authors:  R M Warn; P Dowrick
Journal:  Nature       Date:  1989-07-20       Impact factor: 49.962

3.  Fourier analysis of cell motility: correlation of motility with metastatic potential.

Authors:  A W Partin; J S Schoeniger; J L Mohler; D S Coffey
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

Review 4.  Molecular aspects of tumor cell invasion and metastasis.

Authors:  S Aznavoorian; A N Murphy; W G Stetler-Stevenson; L A Liotta
Journal:  Cancer       Date:  1993-02-15       Impact factor: 6.860

Review 5.  Tumor heterogeneity.

Authors:  G H Heppner
Journal:  Cancer Res       Date:  1984-06       Impact factor: 12.701

6.  The effects of basic fibroblast growth factor and suramin on cell motility and growth of rat prostate cancer cells.

Authors:  K J Pienta; W B Isaacs; D Vindivich; D S Coffey
Journal:  J Urol       Date:  1991-01       Impact factor: 7.450

7.  Insulin-like growth factors stimulate chemotaxis in human melanoma cells.

Authors:  M L Stracke; E C Kohn; S A Aznavoorian; L L Wilson; D Salomon; H C Krutzsch; L A Liotta; E Schiffmann
Journal:  Biochem Biophys Res Commun       Date:  1988-06-30       Impact factor: 3.575

8.  Differential suppression of mammary and prostate cancer metastasis by human chromosomes 17 and 11.

Authors:  C W Rinker-Schaeffer; A L Hawkins; N Ru; J Dong; G Stoica; C A Griffin; T Ichikawa; J C Barrett; J T Isaacs
Journal:  Cancer Res       Date:  1994-12-01       Impact factor: 12.701

9.  Metastatic potential prediction by a visual grading system of cell motility: prospective validation in the Dunning R-3327 prostatic adenocarcinoma model.

Authors:  J L Mohler; A W Partin; J T Isaacs; D S Coffey
Journal:  Cancer Res       Date:  1988-08-01       Impact factor: 12.701

Review 10.  Cell motility, a principal requirement for metastasis.

Authors:  M L Stracke; S A Aznavoorian; M E Beckner; L A Liotta; E Schiffmann
Journal:  EXS       Date:  1991
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.